Caldan Therapeutics

Recent Finacing

Equity

Recent Raise

$1.8M

Caldan Therapeutics is a Glasgow-based university spinout developing GPR120/free fatty acid receptor agonists, optimizing a lead candidate toward later preclinical development for NASH and type 2 diabetes.

Founded 2014

Edinburgh, City of, United Kingdom

1-10

Private

caldantherapeutics.com

Highlights

Focus Areas

Biotechnology

Collaboration

Medical

Therapeutics

Recent Investors

Financials

$8.5M

Total Raised

2

Funding rounds

3

Investors

Team

Upgrade to view the team

See the team members at Caldan Therapeutics.